Updated Mar. 29, 2014 at 1:07 p.m.

Premium Lock Scynexis lands Russian partner for anti-fungal drug headed for phase II trials

Published: 2013-09-10 19:13:00
Updated: 2014-03-29 13:07:13

Print this blog post
Scynexis Scynexis

The deal expands the market potential for an anti-fungal compound Scynexis originally partnered with Merck. Read about why this drug could have an advantage other anti-fungals in its class....

Read More
Read More

WRAL Tech Wire any time: Twitter, Facebook

Copyright 2014 WRAL Tech Wire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL Tech Wire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Frank Vinluan
Life science
Dr. Mike Walden
Tech economy
Vivek Wadhwa
Commentary
Scroll